D. E. Shaw & Co., Inc. Organogenesis Holdings Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 632,744 shares of ORGO stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

632,744

Previous 966,872 34.56%

Holding current value

$1.78 Million

Previous $3.95 Million 54.58%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $872,074 - $1.5 Million	-334,128 Reduced 34.56%	632,744 $1.8 Million
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $235,111 - $502,446	-119,346 Reduced 10.99%	966,872 $3.95 Million
Q3 2023 Nov 14, 2023	SELL	$2.34 - $4.43 $432,307 - $818,429	-184,747 Reduced 14.54%	1,086,218 $3.45 Million
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $132,768 - $300,475	-69,878 Reduced 5.21%	1,270,965 $4.22 Million
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $1.72 Million - $2.66 Million	909,003 Added 210.5%	1,340,843 $2.86 Million

Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $587,913 - $813,122	237,062 Added 121.71%	431,840 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $136,662 - $279,852	43,523 Added 28.77%	194,778 $631,000
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $414,702 - $713,043	87,490 Added 137.21%	151,255 $738,000
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $82,427 - $121,921	-12,740 Reduced 16.65%	63,765 $486,000
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $512,444 - $766,962	-56,812 Reduced 42.61%	76,505 $707,000
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $1.22 Million - $1.52 Million	88,723 Added 198.96%	133,317 $1.9 Million
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $665,342 - $1.04 Million	44,594 New	44,594 $741,000

Others Institutions Holding ORGO

# of Institutions

129

Shares Held

56.3M

Call Options Held

55.3K

Put Options Held

22.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $368M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account